Stephens & Co. Maintains Equal-Weight on Tenet Healthcare, Raises Price Target to $122
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel maintains an Equal-Weight rating on Tenet Healthcare (NYSE:THC) and raises the price target from $95 to $122.
May 01, 2024 | 11:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. maintains an Equal-Weight rating on Tenet Healthcare and increases the price target to $122.
The increase in price target by Stephens & Co. reflects a positive outlook on Tenet Healthcare's stock, suggesting potential upside. This could lead to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100